Cours Innovus Pharmaceuticals Inc Other OTC
Actions
US45778V1061
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,98% | 682 Md | |
+32,39% | 586 Md | |
-3,52% | 364 Md | |
+18,59% | 327 Md | |
+4,07% | 285 Md | |
+16,50% | 240 Md | |
+9,56% | 209 Md | |
-9,04% | 203 Md | |
+7,09% | 165 Md |